Abstract:Pancreatic cancer is known to have a high mortality rate, and its early diagnosis remains challenging due to the occult location of the pancreas. Exosomes derived from pancreatic cancer cells specifically express glypican-1, which may provide a liquid biopsy opportunity for the early diagnosis of pancreatic cancer. Herein, an inductively coupled plasma mass spectrometry (ICP-MS) and photothermal dual-readout platform was proposed for the ultrasensitive and point-of-care analysis of pancreatic cancer exosomes. In our design, exosomes were specifically captured by the sandwich immunoassay, and simultaneously, alkaline phosphatase was introduced in a low-background manner. The alkaline phosphatase triggered the hydrolysis of l-ascorbic acid 2-phosphate to produce ascorbic acid, followed by the etching of Fe3O4@MnO2 nanoflowers. As a result, the Mn2+ generated by etching stripped off the Fe3O4 and was quantified using ICP-MS. Meanwhile, the reduced Fe3O4@MnO2 was applied for the photothermal assay by oxidizing dopamine with MnO2. The protocol exhibits a detection limit down to 19.1 particles mL–1, which is the most sensitive protocol reported so far. To our knowledge, this is the first endeavor for exosome quantification using ICP-MS and photothermal methods. The developed dual-readout platform not only is capable of distinguishing pancreatic cancer patients from healthy people, but also shows excellent discernibility of individual differences at low concentrations of exosomes. This dual-readout assay is a promising platform for the ultrasensitive and point-of-care detection of exosomes in liquid biopsy-based early cancer diagnosis.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02004.Chemicals and materials; Cell culture and exosome isolation; Schematic illustration of preparing Fe3O4@MnO2 nanoflowers; Schematic illustration of ALP-induced etching of Fe3O4@MnO2 nanoflowers; Characterization of exosomes isolated by the ultracentrifugation and magnetic separation; UV–vis absorption spectra of polydopamine nanoparticles and dopamine; Optimization of experimental parameters; Table of operating parameters for ICP-MS detection of exosomes; and Table of comparison of the developed method with the reported methods for exosome quantification (PDF)This article has not yet been cited by other publications.

A smart tablet-phone-based high-performance pancreatic cancer cell biosensing system for drug screening

3D Cell-Based Biosensor for Cell Viability and Drug Assessment by 3D Electric Cell/matrigel-Substrate Impedance Sensing.

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

Highly sensitive microfluidic sensor using integrated optical fiber and real-time single-cell Raman spectroscopy for diagnosis of pancreatic cancer

A smart tablet-phone-based system using dynamic light modulation for highly sensitive colorimetric biosensing

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Drug screening on digital microfluidics for cancer precision medicine

Combining Scalable Organ Chip Platform with Deep Learning-Based Imaging Analysis for Cancer Therapeutic Screening

Synergistically enhanced colorimetric molecular detection using smart cup: a case for instrument-free HPV-associated cancer screening

A portable smartphone detection of ctDNA using MnB2 nanozyme and paper-based analytical device

ICP-MS and Photothermal Dual-Readout Assay for Ultrasensitive and Point-of-Care Detection of Pancreatic Cancer Exosomes

Cascaded nanozyme-based high-throughput microfluidic device integrating with glucometer and smartphone for point-of-care pheochromocytoma diagnosis

A high throughput blood-based assay for the early detection of pancreatic cancer

A digital microfluidic device integrated with electrochemical sensor and 3D matrix for detecting soluble PD-L1

Inspired by game theory: Multi-signal output photoelectrochemical point-of-care immunoassay based on target-triggered organic electronic barriers

Single hollow-core microstructure fiber biosensor for pancreatic cancer diagnosis in terahertz regime

Drug screening of cancer cell lines and human primary tumors using droplet microfluidics

Nanoporous Glass Integrated in Volumetric Bar-Chart Chip for Point-of-Care Diagnostics of Non-Small Cell Lung Cancer.

Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform

Smartphone Biosensor System with Multi-Testing Unit Based on Localized Surface Plasmon Resonance Integrated with Microfluidics Chip

Smartphone-assisted self-powered dual-mode biosensor designed on binary 3D DNA Walkers mediated CRISPR/Cas12a system